Tri-tert-butyl 1,4,7,10-Tetraazacyclododecane-1,4,7-triacetate Hydrobromide, 97%, 5g

6-(Trifluoromethoxy)quinolin-2(1H)-one, 1g

(3aS,3a'S,8aR,8a'R)-2,2'-(Cyclopropane-1,1-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole), 98.0%, 5g

2-[(2,4-Difluorophenyl)thio]ethanol, 98.0%, 5g

Z-L-glutamic acid g-tert-butyl ester a-methyl ester, 98.0%, 10g

(R)-2-BROMO-1-(4-BROMOPHENYL)ETHANOL, 90.0%, 500mg

2-Methoxyethanol, min. 99%, for synthesis, 2.5 L, glass packaging

(S)-imino(methyl)(phenyl)-lambda6-sulfanone, 98%, 1g

HPLC Guard Columns (analytical) NUCLEODUR® C18 Gravity 1.8 µm, 3 Piece(s)

5-O-tert-butyl 1-O-(2,5-dioxopyrrolidin-1-yl) (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]pentanedioate, 99%, 100g

2-Phenoxyacetamidine hydrochloride, 95.0%, 5g

Dimethyl Glutarate>98.0%(GC)25g

3-((((9h-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylpropanoic acid, 95+%, 100mg